Challenges and perspectives in the immunotherapy of Hodgkin lymphoma. [electronic resource]
- European journal of cancer (Oxford, England : 1990) 11 2017
- 67-77 p. digital
Publication Type: Journal Article; Review
1879-0852
10.1016/j.ejca.2017.08.014 doi
Adolescent Adult Aged Aged, 80 and over Antibodies--adverse effects Antineoplastic Agents--adverse effects Biomarkers, Tumor--antagonists & inhibitors Child Hodgkin Disease--genetics Humans Immunotherapy--adverse effects Middle Aged Molecular Targeted Therapy Programmed Cell Death 1 Receptor--antagonists & inhibitors Reed-Sternberg Cells--drug effects Signal Transduction--drug effects Treatment Outcome Tumor Escape--drug effects Tumor Microenvironment Young Adult